Financial News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023 at 18:56 PM EDT
Donanemab slowed the decline in memory, in thinking and in the ability to conduct daily activities by 35%, according to Lilly's data.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
